Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
957 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07528586 | Serial Cardiac Magnetic Resonance Imaging (CMR) With Contrast Agents and Biomarker Analysis for the Detection of Cardiotoxicity Under Anthracycline-containing Cancer Therapy(CMR-Onko) | recruiting | N/A | 93 | Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)OTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT06064877 | A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma(FIERCE-HN) | recruiting | Phase 3 | 410 | AVEO Pharmaceuticals, Inc. |
| 18 |
| Apr 9, 2026 |
| clinicaltrials |
| NCT07221838 | A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab(OCTAGON) | recruiting | Phase 4 | 75 | Alexion Pharmaceuticals, Inc.INDUSTRY | 4 | Apr 9, 2026 | clinicaltrials |
| NCT06146010 | Non Interventional German Leptomeningeal Disease Register | recruiting | — | 50 | University Hospital TuebingenOTHER | 1 | Apr 8, 2026 | clinicaltrials |
| NCT05203172 | The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials | recruiting | Phase 4 | 46 | PfizerINDUSTRY | 17 | Apr 7, 2026 | clinicaltrials |
| NCT04294927 | TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention(TUBA-WISP-II) | recruiting | N/A | 3,000 | University Medical Center NijmegenOTHER | 16 | Apr 6, 2026 | clinicaltrials |
| NCT06522737 | A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype(TERZO) | recruiting | Phase 3 | 124 | SecuraBioINDUSTRY | 10 | Apr 6, 2026 | clinicaltrials |
| NCT05483374 | The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers(EURACAN) | recruiting | — | 13,600 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 3 | Apr 3, 2026 | clinicaltrials |
| NCT06408441 | The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)(EHE) | recruiting | — | 100 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 10 | Apr 3, 2026 | clinicaltrials |
| NCT06867705 | Randomized Controlled Trial of Remote Symptoms Monitoring With Resilience PRO Compared to Care As Usual Only(RC-102) | recruiting | Phase 3 | 1,458 | ResilienceINDUSTRY | 2 | Apr 3, 2026 | clinicaltrials |
| NCT07510724 | Real-World Data on the Treatment of Lung Cancer Patients With the Immune-Checkpoint Inhibitor Tislelizumab(IKF-ReWoLuTe) | recruiting | — | 240 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestOTHER | 2 | Apr 3, 2026 | clinicaltrials |
| NCT05304377 | A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia(CML) | recruiting | Phase 1 | 250 | Enliven TherapeuticsINDUSTRY | 14 | Apr 1, 2026 | clinicaltrials |
| NCT06856902 | BEhavioral and Adherence Model for Improving Quality, Health Outcomes and Cost-Effectiveness of healthcaRe(BEAMER) | recruiting | N/A | 3,100 | Technical University of MadridOTHER | 8 | Apr 1, 2026 | clinicaltrials |
| NCT07371585 | Trastuzumab Deruxtecan in First-Line HER2-Positive Metastatic Breast Cancer With Proactive Toxicity Management(TOP-REAL) | recruiting | Phase 2 | 300 | SOLTI Breast Cancer Research GroupOTHER | 3 | Mar 27, 2026 | clinicaltrials |
| NCT04185974 | Carbon Ion Re-Radiotherapy in Patients With Recurrent or Progressive Locally Advanced Head-and-Neck Cancer(CARE) | recruiting | N/A | 72 | University Hospital HeidelbergOTHER | 1 | Mar 25, 2026 | clinicaltrials |
| NCT06093672 | Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera(GIV-IN-PV) | recruiting | Phase 3 | 220 | ItalfarmacoINDUSTRY | 16 | Mar 25, 2026 | clinicaltrials |
| NCT06932562 | A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant | recruiting | Phase 3 | 1,000 | European Myeloma Network B.V.NETWORK | 18 | Mar 25, 2026 | clinicaltrials |
| NCT07491328 | Liquid Biopsy in Paraneoplastic Neurological Syndromes(LiB-PNS) | recruiting | — | 60 | Heinrich-Heine University, DuesseldorfOTHER | 1 | Mar 24, 2026 | clinicaltrials |
| NCT07487428 | CLL-IMPACT: A Clinical Nutrition Trial Investigating Immune and Metabolic Changes in Early-Stage CLL(CLL-IMPACT) | recruiting | N/A | 50 | Technical University of MunichOTHER | 1 | Mar 23, 2026 | clinicaltrials |
| NCT04655404 | A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion | recruiting | Early Phase 1 | 15 | Nationwide Children's HospitalOTHER | 5 | Mar 18, 2026 | clinicaltrials |
| NCT06153251 | A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma | recruiting | Phase 1 | 187 | Juno Therapeutics, Inc., a Bristol-Myers Squibb CompanyINDUSTRY | 4 | Mar 18, 2026 | clinicaltrials |
| NCT06047236 | Immune Biomarker Study for Salivary Gland Carcinoma(ImmoGlandula) | recruiting | — | 300 | University of Erlangen-Nürnberg Medical SchoolOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT06030440 | De-Intensification of Postoperative Radiotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck(DIREKHT2) | recruiting | Phase 2 / Phase 3 | 508 | University of Erlangen-Nürnberg Medical SchoolOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT06464198 | Prospective Registry Study on the Implementation of Simultaneous Postoperative Radiochemotherapy for Salivary Gland Carcinomas of the Head and Neck Region | recruiting | — | 100 | University of Erlangen-Nürnberg Medical SchoolOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT06768918 | Digitizing Cancer Rehabilitation During and After Systemic Treatment: Feasibility Testing Implementation in South Baltic Countries(AMBeR eRehab) | recruiting | N/A | 300 | Zealand University HospitalOTHER | 5 | Mar 12, 2026 | clinicaltrials |
| NCT06835218 | PROCARE - PROstate Cancer Real World Evidence Registry(PROCARE) | recruiting | — | 5,000 | UroTrials Company (GmbH)NETWORK | 1 | Mar 12, 2026 | clinicaltrials |
| NCT06981325 | Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell Carcinoma (BCC) Patients(CEMI-first) | recruiting | Phase 2 | 34 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestOTHER | 1 | Mar 11, 2026 | clinicaltrials |
| NCT07464457 | Effects of Neoadjuvant Prehabilitation on Post-Interventional Physical and Psychological Outcomes in Oncology Patients With Solid Tumors(NEOPRO-SIT) | recruiting | N/A | 125 | Priv.-Doz. Dr. med. Philipp LenzOTHER | 1 | Mar 11, 2026 | clinicaltrials |
| NCT04094454 | Intrafractional Vaginal Dilation in Anal Cancer Patients Undergoing Pelvic Radiotherapy(DILANA) | recruiting | N/A | 60 | Juergen DebusOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT04219202 | Neoadjuvant Irradiation of Retroperitoneal Soft Tissue Sarcoma With Ions Retro-Ion(Retro-Ion) | recruiting | N/A | 64 | University Hospital HeidelbergOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT05378633 | The CyberChallenge Trial How Much is Too Much - What is the Role of Cyberknife Radiosurgery in Patients With Multiple Brain Metastases?(CyberChallenge) | recruiting | N/A | 190 | University Hospital HeidelbergOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT06104930 | Plasma Extracellular Vesicles in Meningioma Patients(MOLI) | recruiting | N/A | 60 | University Hospital HeidelbergOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT06408116 | Predicting Esophageal Cancer Borders Using PET-Imaging(PEGASUS) | recruiting | Phase 2 | 30 | University Hospital HeidelbergOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT06954623 | Partial Breast Re-irradiation for Breast Cancer(BREAST) | recruiting | N/A | 20 | University Hospital HeidelbergOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT04083937 | Prostate Cancer Patients Treated With Alternative Radiation Oncology Strategies(PAROS) | recruiting | N/A | 897 | University Hospital HeidelbergOTHER | 1 | Mar 9, 2026 | clinicaltrials |
| NCT06142760 | MR-guidance in Chemoradiotherapy for Cervical Cancer(AIM-C1) | recruiting | N/A | 40 | Juergen DebusOTHER | 1 | Mar 9, 2026 | clinicaltrials |
| NCT04075305 | The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study(MOMENTUM) | recruiting | — | 8,000 | UMC UtrechtOTHER | 9 | Mar 5, 2026 | clinicaltrials |
| NCT05124236 | Trial of Preoperative Radiosurgery Versus Postoperative Stereotactic Radiotherapy for Resectable Brain Metastases(PREOP-2) | recruiting | N/A | 200 | Susanne RogersOTHER | 3 | Mar 4, 2026 | clinicaltrials |
| NCT06532006 | A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer | recruiting | Phase 3 | 550 | Shanghai Henlius BiotechINDUSTRY | 17 | Feb 27, 2026 | clinicaltrials |
| NCT06809101 | Home Monitoring of Complete Blood Count Performed by Patients - a Pilot Study on the Implementation Process in South Baltic Countries.(AMBeR eBlood) | recruiting | — | 265 | Pomeranian Medical University SzczecinOTHER | 3 | Feb 27, 2026 | clinicaltrials |
| NCT02790983 | Primary Tumor Research and Outcomes Network(PTRON) | recruiting | — | 1,350 | AO Innovation Translation CenterOTHER | 9 | Feb 25, 2026 | clinicaltrials |
| NCT05549297 | Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM) | recruiting | Phase 3 | 540 | Immunocore LtdINDUSTRY | 12 | Feb 25, 2026 | clinicaltrials |
| NCT06112314 | IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)(PRISM-MEL-301) | recruiting | Phase 3 | 680 | Immunocore LtdINDUSTRY | 26 | Feb 25, 2026 | clinicaltrials |
| NCT06657157 | Peripheral Neuropathy in Patients Receiving Enfortumab Vedotin and Pembrolizumab as First Line Treatment for Metastatic or Locally Advanced Urothelial Carcinoma(P-EVOLUTION) | recruiting | — | 80 | Comprehensive Cancer Center Munich (CCCM)OTHER | 1 | Feb 24, 2026 | clinicaltrials |
| NCT06877949 | FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer(MONITOR-RCT) | recruiting | N/A | 420 | Odense University HospitalOTHER | 3 | Feb 20, 2026 | clinicaltrials |
| NCT03463954 | Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors | recruiting | N/A | 122 | Novian Health Inc.INDUSTRY | 5 | Feb 19, 2026 | clinicaltrials |
| NCT04202341 | Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs) | recruiting | — | 500 | Alexion Pharmaceuticals, Inc.INDUSTRY | 7 | Feb 18, 2026 | clinicaltrials |
| NCT04833894 | Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis(ADAPT Jr) | recruiting | Phase 2 / Phase 3 | 12 | argenxINDUSTRY | 12 | Feb 18, 2026 | clinicaltrials |
| NCT05879757 | Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency | recruiting | — | 75 | TakedaINDUSTRY | 11 | Feb 18, 2026 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials